Frédéric Amant, Michael J Halaska, Monica Fumagalli, Karina Dahl Steffensen, Christianne Lok, Kristel Van Calsteren, Sileny N Han, Olivier Mir, Robert Fruscio, Cathérine Uzan, Cynthia Maxwell, Jana Dekrem, Goedele Strauven, Mina Mhallem Gziri, Vesna Kesic, Paul Berveiller, Frank van den Heuvel, Petronella B Ottevanger, Ignace Vergote, Michael Lishner, Philippe Morice, Irena Nulman
OBJECTIVES: This study aimed to provide timely and effective guidance for pregnant women and health care providers to optimize maternal treatment and fetal protection and to promote effective management of the mother, fetus, and neonate when administering potentially teratogenic medications. New insights and more experience were gained since the first consensus meeting 5 years ago. METHODS: Members of the European Society of Gynecological Oncology task force "Cancer in Pregnancy" in concert with other international experts reviewed the existing literature on their respective areas of expertise...
March 2014: International Journal of Gynecological Cancer